Aureka Biotechnologies Raises $100M to Advance Growth
Aureka Biotechnologies announced the close of a US$100 million Series B financing. Granite Asia funded the first tranche exclusively, and a prominent strategic investor led a subsequent tranche, with participation from HighLight Capital (HLC) and follow-on investment from existing shareholders including MPCi and NRL C…
